Clover Health Files 8-K

TL;DR

CLOV filed an 8-K on 6/26/24, mostly corporate housekeeping and past name changes.

AI Summary

Clover Health Investments Corp. filed an 8-K on June 26, 2024, reporting on other events and financial statements. The filing details the company's corporate structure and historical name changes, including its previous name Social Capital Hedosophia Holdings Corp. III.

Why It Matters

This 8-K filing provides an update on Clover Health's corporate information and historical changes, which is important for investors to track the company's evolution.

Risk Assessment

Risk Level: low — The filing appears to be routine corporate disclosure and does not indicate any immediate financial distress or significant operational changes.

Key Players & Entities

• CLOVER HEALTH INVESTMENTS, CORP. /DE (company) — Registrant
• Social Capital Hedosophia Holdings Corp. III (company) — Former Company Name
• June 26, 2024 (date) — Date of Report
• 3401 Mallory Lane, Suite 210 Franklin, Tennessee 37067 (address) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market

Filing Documents

• clov-20240626.htm (8-K) — 30KB
• exhibit991-pressreleaseoft.htm (EX-99.1) — 8KB
• 0001801170-24-000137.txt ( ) — 166KB
• clov-20240626.xsd (EX-101.SCH) — 2KB
• clov-20240626_lab.xml (EX-101.LAB) — 22KB
• clov-20240626_pre.xml (EX-101.PRE) — 13KB
• clov-20240626_htm.xml (XML) — 3KB

01. Other Events

Item 8.01. Other Events On June 26, 2024, Clover Health Investments, Corp. (the "Company") issued a press release announcing that on June 26, 2024 it received written notice from The Nasdaq Stock Market ("Nasdaq") notifying the Company that it has regained compliance with Nasdaq's minimum stock price requirement. A copy of the press release announcing the written notice described herein is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Forward-Looking Statements

Forward-Looking Statements Please note that this report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements regarding future events and the Company's future results of operations, financial position, business strategy and future plans. Forward-looking statements are not guarantees of future performance, and you are cautioned not to place undue reliance on such statements. In some cases, you can identify forward looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "going to," "can," "could," "should," "would," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," "outlook," "forecast," "guidance," "objective," "plan," "seek," "grow," "target," "if," "continue," or the negative of these words or other similar terms or expressions that concern the Company's expectations, strategy, priorities, plans or intentions. Forward-looking statements in this report include, but are not limited to, statements regarding continued future compliance with Nasdaq listing requirements. These statements are subject to known and unknown risks, uncertainties and other factors that may cause the Company's actual results, levels of activity, performance or achievements to differ materially from results expressed or implied in this report. Additional information concerning these and other risk factors is contained in the Company's latest Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on March 14, 2024, and in our subsequent reports filed with the SEC, in each case where relevant, including the Risk Factors sections therein. The forward-looking statements included in this report are made as of the date hereof. Except as required by law, the Company undertakes no obligation t

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) List of Exhibits Exhibit No. Description 99.1 Press Release of the Company, dated June 26, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Clover Health Investments, Corp. Date: June 26, 2024 By: /s/Karen M. Soares Name: Karen M. Soares Title: General Counsel and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR